Cabaletta Bio (CABA) Depreciation & Amortization (CF) (2019 - 2025)

Cabaletta Bio's (CABA) quarterly Depreciation & Amortization (CF) came in at $348000.0 in Q4 2025, down 25.64% year-on-year from $468000.0 in Q4 2024, and up 0.87% quarter-over-quarter from $345000.0 in Q3 2025.

Cabaletta Bio (CABA) Depreciation & Amortization (CF) (2019 - 2025) Analysis & Trends

Cabaletta Bio's Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $348000.0 for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 25.64% year-over-year to $348000.0 in Q4 2025; TTM through Dec 2025 was $1.6 million, a 3.8% decrease from a year earlier, with the FY2025 full-year figure at $1.6 million, down 3.8% from the prior year.
  • Depreciation & Amortization (CF) rose to $348000.0 in Q4 2025 per CABA's latest filing, from $345000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $485000.0 in Q1 2025 and bottomed at $116000.0 in Q1 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $356500.0 (2022), against an average of $334700.0.
  • Across the five-year window, Depreciation & Amortization (CF) surged 145.56% in 2021 and retreated 25.64% in 2025, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $234000.0 in 2021, then jumped by 52.99% to $358000.0 in 2022, then fell by 6.15% to $336000.0 in 2023, then soared by 39.29% to $468000.0 in 2024, then slipped by 25.64% to $348000.0 in 2025.
  • Per Business Quant, the three latest CABA Depreciation & Amortization (CF) figures stand at $348000.0 (Q4 2025), $345000.0 (Q3 2025), and $468000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Cabaletta Bio 182.04 Mn 182.04 Mn - 348,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 348,000.00
Dec 31, 2025 348,000.00
Sep 30, 2025 345,000.00
Sep 30, 2025 345,000.00
Jun 30, 2025 468,000.00
Jun 30, 2025 468,000.00
Mar 31, 2025 485,000.00
Mar 31, 2025 485,000.00
Dec 31, 2024 468,000.00
Dec 31, 2024 468,000.00
Sep 30, 2024 424,000.00
Sep 30, 2024 424,000.00
Jun 30, 2024 426,000.00
Jun 30, 2024 426,000.00
Mar 31, 2024 393,000.00
Mar 31, 2024 393,000.00
Dec 31, 2023 336,000.00
Dec 31, 2023 336,000.00
Sep 30, 2023 355,000.00
Sep 30, 2023 355,000.00